Viewing Study NCT01120093


Ignite Creation Date: 2025-12-25 @ 12:58 AM
Ignite Modification Date: 2025-12-25 @ 11:12 PM
Study NCT ID: NCT01120093
Status: COMPLETED
Last Update Posted: 2017-01-09
First Post: 2010-05-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Three Doses of Aclidinium Bromide Compared to Placebo and to an Active Comparator in Chronic Obstructive Pulmonary Disease (COPD) Patients.
Sponsor: AstraZeneca
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2010-05
Start Date Type: None
Primary Completion Date: 2010-08
Primary Completion Date Type: ACTUAL
Completion Date: 2010-08
Completion Date Type: ACTUAL
First Submit Date: 2010-05-07
First Submit QC Date: None
Study First Post Date: 2010-05-10
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2012-08-14
Results First Submit QC Date: None
Results First Post Date: 2012-09-12
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-11-17
Last Update Post Date: 2017-01-09
Last Update Post Date Type: ESTIMATED